Skip to main content
SpringerLink
Log in

Peri-urethral Injections

  • Chapter
  • First Online:
Office-Based Gynecologic Surgical Procedures

  • 947 Accesses

Abstract

Peri-urethral bulking agents have evolved since the 1930s and remain a viable option for treatment of stress urinary incontinence (SUI) in selected patient populations. We review the history of urethral bulking and complication data from historically used bulking agents. We discuss success and complication data for agents currently available for urethral bulking in the USA. Additionally, we review troubleshooting and use instructions for each of these urethral bulking therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

PBA:

Peri-urethral bulking agent

SUI:

Stress urinary incontinence

References

  1. Albo ME, Litman HJ, Richter HE, Lemack GE, Sirls LT, Chai TC, et al. Treatment success of retropubic and transobturator mid urethral slings at 24 months. J Urol. 2012;188:2281–7.

    Article  PubMed  Google Scholar 

  2. American Urologic Association Pocket Guide May 15, 2013 for Urologic Surgery Antimicrobial Prophylaxis. http://www.auanet.org/common/pdf/education/clinical-guidance/Antimicrobial-Prophylaxis-PocketTable.pdf. Accessed 6 Oct 2013.

  3. Andersen RCM. Long-term follow-up comparison of Durasphere and Contigen in the treatment of stress urinary incontinence. J Low Genit Tract Dis. 2002;6:239–43.

    Article  PubMed  Google Scholar 

  4. Cao H. Mechanical performance of pyrolytic carbon in prosthetic heart valve applications. J Heart Valve Dis. 1996;5(1):S32–49.

    Google Scholar 

  5. Belafsky PC, Postma GN. Vocal cord augmentation with calcium hydroxylapatite. Otolaryngol Head Neck Surg. 2004;131(4):351–4.

    Article  PubMed  Google Scholar 

  6. Bent AE, Foote J, Siegel S, Faerber G, Chaos R, Gormley EA. Collagen implant for treating stress urinary incontinence in women with urethral hypermobility. J Urol. 2001;166:1354–7.

    Article  PubMed  CAS  Google Scholar 

  7. Bent AE, Tutrone RT, McLennan MT, Lloyd LK, Kennelly MJ, Badlani G. Treatment of intrinsic sphincter deficiency using autologous ear chondrocytes as a bulking agent. Neurourol Urodyn. 2001;20:157–65.

    Article  PubMed  CAS  Google Scholar 

  8. Berg S. Polytef augmentation urethroplasty. Arch Surg. 1973;201:379–81.

    Article  Google Scholar 

  9. Berger MB, Morgan DM. Delayed presentation of pseudoabscess secondary to injections of pyrolytic carbon-coated beads bulking agent. Female Pelvic Med Reconstr Surg. 2012;18:303–5.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Bridges MD, Petrou SP, Lightner DJ. Urethral bulking agents: imaging review. AJR Am J Roentgenol. 2005;185:257–64.

    Google Scholar 

  11. Carr LK, Steele D, Steele S, Wagner D, Pruchnic R, Jankowski R, Erickson J, Huard J, Chancellor MB. 1-year follow-up of autologous muscle derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J. 2008;19:881–3.

    Article  CAS  Google Scholar 

  12. Cerruto MA, Zattoni F. Bulking agents: anesthesia techniques. Urologia. 2009;76:45–8.

    PubMed  CAS  Google Scholar 

  13. Corcos J, Collet JP, Shapiro S, Herschorn S, Radomski SB, Schick E, et al. Multicenter randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence. Urology. 2005;65:898–904.

    Article  PubMed  CAS  Google Scholar 

  14. Coaptite® injectable implant procedure guide. www.bostonscientific.com/gynecology, Accessed 10 Oct 2013.

  15. Durasphere EXP® office procedure guide. www.us.coloplast.com, Accessed 10 Oct 2013.

  16. Dmochowski RR, Appell RA. Injectible agents in the treatment of stress urinary incontinence in women: where are we now? Urology. 2000;56(S6A):32–40.

    Article  PubMed  CAS  Google Scholar 

  17. Erekson EA, Sung VW, Rardin CR, Myers DL. Ethylene vinyl alcohol copolymer erosion after use as a urethral bulking agent. Obstet Gynecol. 2007;109:490–2.

    Article  PubMed  CAS  Google Scholar 

  18. Faerber GJ. Endoscopic collagen injection therapy in elderly women with type I stress urinary incontinence. J Urol. 1996;155:512–4.

    Article  PubMed  CAS  Google Scholar 

  19. de Garibay AS G, Castillo-JImenco JM, York M, Gomez P, Sebastian-Borruel JL. Endoscopic autotransplantation of fat tissues in the treatment of urinary incontinence in the female. J Urol (Paris). 1989;95:363.

    Google Scholar 

  20. Ghoniem G, Corcos J, Comiter C, Bernhard P, Westney OL, Herschorn S. Cross-linked polymethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled single-blind study. J Urol. 2009;181:204–10.

    Article  PubMed  Google Scholar 

  21. Ghoniem G, Corcos J, Comiter C, Bernhard P, Westney OL, Herschorn S. Durability of urethral bulking agent injection for female stress urinary incontinence: 2 year multicenter study results. J Urol. 2010;183:1444–9.

    Article  PubMed  Google Scholar 

  22. Ghoniem GM, Khater U. Urethral prolapse after durasphere injection. Int Urogynecol J. 2006;17:297–8.

    Article  Google Scholar 

  23. Gopinath D, Smith AR, Reid FM. Periurethral abscess following polyacrylamide hydrogel (Bulkamid) for stress urinary incontinence. Int Urogynecol J. 2012;23:1645–48.

    Article  PubMed  CAS  Google Scholar 

  24. Haab F, Zimmern PE, Leach GE. Urinary stress incontinence due to intrinsic sphincteric deficiency: experience with fat and collagen periurethral injections. J Urol. 1997;157:1283–6.

    Article  PubMed  CAS  Google Scholar 

  25. Harriss DR, Iacovou JW, Lemberger RJ. Peri-urethral silicone microimplants (Macroplastique) for the treatment of genuine stress incontinence. Br J Urol. 1996;78:722–8.

    Article  PubMed  CAS  Google Scholar 

  26. Henley DR, Barrett DM, Weiland TL, O’Connor MK, Malizia AA, Wein AJ. Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J Urol. 1995;153(6):2039–43.

    Article  Google Scholar 

  27. Hurtado EA, Appell RA. Complications of Tegress injections. Int Urogynecol J. 2009;20:127.

    Article  Google Scholar 

  28. Hurtado E, McCrery R, Appell R. The safety and efficacy of ethylene vinyl alcohol copolymer as an intra-urethral bulking agent in women with intrinsic urethral deficiency. In Urogynecol J. 2007;18:869–73.

    Article  Google Scholar 

  29. Kirchin V, Page T, Keegan PE, Atiemo K, Cody JD, Mc Clinton S. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev. 2012;(2):Art No.:CD003881. doi:10.1002/14651858.CD003881.pub3.

  30. Klarsov N. Urethral pressure reflexometry. Dan Med. 2012;59(3):B4412.

    Google Scholar 

  31. Klarsov N, Lose G. Urethral injection therapy: what is the mechanism of action? Neurourol Urodyn. 2008;27:789–92.

    Article  Google Scholar 

  32. Koski ME, Enemchukwu EA, Padmanabhan P, Kaufman MR, Scarpero HM, Dmochowski RR. Safety and efficacy of sling for persistent stress urinary incontinence after bulking injection. Urology. 2011;77:1076–80.

    Article  PubMed  Google Scholar 

  33. Kuhn A, Stadlmayr W, Lengsfeld D, Mueller MD. Where should bulking agents for female urodnamic stress incontinence be injected? Int Urogynecol J. 2008;19:817–21.

    Article  Google Scholar 

  34. Kumar D, Kaufman MR, Dmochowski RR. Case reports: periurethral bulking agents and presumed urethral diverticula. Int Urogynecol J. 2011;22:1039–43.

    Article  PubMed  Google Scholar 

  35. Lee HM, Lee YS, Han JY, Jeong JY, Choo MS, Lee KS. Transurethral injection of bulking agent for treatment of failed mid-urethral sling procedures. Int Urogynecol J. 2010;21:1479–83.

    Article  PubMed  Google Scholar 

  36. Lee PE, Kung RC, Druta HP. Periurethral autologous fat injections as treatment for female stress urinary incontinence: a randomized double-blind controlled trial. J Urol. 2001;165:153–8.

    Article  PubMed  CAS  Google Scholar 

  37. Lightner DJ. Review of the available urethral bulking agents. Curr Opin Urol. 2002;12:333–8.

    Article  PubMed  Google Scholar 

  38. Lightner DJ, Calvosa C, Andersen R, Klimberg I, Brito CG, Snyder J, et al. A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized controlled, double-blind study of Dursphere. Urology. 2001;58:12–5.

    Article  PubMed  CAS  Google Scholar 

  39. Lightner DJ, Fox J, Klingele C. Cystoscopic injections of dextranomer hyaluronic acid into proximal urethra for urethral incompetence: efficacy and adverse outcomes. Urology. 2010;75:1310–4.

    Article  PubMed  Google Scholar 

  40. Lightner DJ, Rovner E, Corcos J, Payne C, Brubaker L, Druta H, et al. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically. Urology. 2009;74:771–77.

    Article  PubMed  Google Scholar 

  41. Maher CF, O’Reilly BA, Dwyer PL, Carey MP, Cornish A, Schluter P. Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomized controlled trial. BJOG. 2005;112:797–801.

    Article  PubMed  Google Scholar 

  42. Malizia AM, Reiman HM, Myers RP. Migration and granulomatous reaction after periurethral injection of Polytef (Teflon). JAMA. 1984;251:3277–81.

    Article  PubMed  Google Scholar 

  43. Mayer RD, Dmochowski RR, Appell RA, Sand PK, Klimberg IW, Jacoby K, Graham CW, Snyder JA, Nitti VW, Winters JC. Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence. Urology. 2007;69:876–80.

    Article  PubMed  CAS  Google Scholar 

  44. Mevorach RA, Hulbert WC, Rabinowitz R, Kennedy A, Kogan BA, Kryger JV, Caldamone A, Clark WR, Kaplan GW, Durkee CT, Elder JS. Results of a 2-year multicenter trial of endoscopic treatment of vesicoureteral reflux with synthetic calcium hydroxyapatite. J Urol. 2006;175:288–91.

    Article  PubMed  Google Scholar 

  45. Murless BC. The injection treatment of stress incontinence. J Obstet Gynaecol Br Emp. 1938;45:521.

    Article  Google Scholar 

  46. Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300:1311–6.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  47. Oliphant SS, Wang L, Bunker CH, Lowder JL. Trends in stress urinary incontinence inpatient procedures in the United States, 1979-2004. Am J Obstet Gynecol. 2009;200(5):521.e1–6.

    Google Scholar 

  48. Palma PCR, Riccetto CLZ, Martins MHT, Herrmann V, de Fraga R, Billis A, et al. Massive prolapse of the urethral mucosa following injection of calcium hydroxylapatitie for stress urinary incontinence. Int Urogynecol J. 2006;17:670–1.

    Article  Google Scholar 

  49. Pannek J, Brands FH, Senge T. Particle migration after transurethral injections of carbon coated beads for stress urinary incontinence. J Urol. 2001;166:1350–3.

    Article  PubMed  CAS  Google Scholar 

  50. Politano VA, Small MP, Harper JM, Lynne CM. Periurethral Teflon injection for urinary incontinence. J Urol. 1974;111:180.

    PubMed  CAS  Google Scholar 

  51. Quackels R. Two cases of incontinence after adenomectomy cured by paraffine injection into the perineum. Acta Urol Belg. 1955;23(3):259–62 [in French].

    PubMed  CAS  Google Scholar 

  52. Richter HE, Albo ME, Zyczynski HM, Kenton K, Norton PA, Sirls LT, et al. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med. 2010;362:2066–76.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  53. Schulz JA, Nager CW, Stanton SL, Baessler K. Bulking agents for stress urinary incontinence: short-term results and complications in a randomized comparison of peri-urethral and transurethral injections. Int Urogynecol J. 2004;15:261–5.

    Google Scholar 

  54. Sebe P, Doucet C, Cornu J, Ciofu C, Costa P, de Medina SGD, et al. Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study. Int Urogynecol J. 2011;22:183–9.

    Article  PubMed  Google Scholar 

  55. Smith DP, Kaplan WE, Oyasu R. Evaluation of polymethylsiloxane as an alternative in the endoscopic treatment of vesicoureteral reflux. J Urol. 1994;152:1221–4.

    PubMed  CAS  Google Scholar 

  56. Solomon LZ, Birch BR, Cooper AJ, Davies CL, Holmes SAV. Nonhomologous bioinjectable materials in urology: ‘size matters’? BJU Int. 2000;85:641–5.

    Article  PubMed  CAS  Google Scholar 

  57. Stamey TA. Urinary incontinence in the female: stress urinary incontinence. In: Harrison JH, Gittes RF, Ad P, editors. Campbells’ urology. 4th ed. Philadelphia: WB Saunders; 1979. p. 2272–93.

    Google Scholar 

  58. Steele AC, Kohli N, Karram MM. Peri-urethral collagen injection for stress incontinence with and without urethral hypermobility. Obstet Gynecol. 2000;95:327.

    Article  PubMed  CAS  Google Scholar 

  59. Sweat SD, Lightner DJ. Complications of sterile abscess formation and pulmonary embolism following periurethral bulking agents. J Urol. 1999;161:93–6.

    Article  PubMed  CAS  Google Scholar 

  60. ter Meulen PH, Berghmans LC, Neiman FH, van Kerrebroeck PE. Effects of Macroplastique implantation system for stress urinary incontinence and urethral hypermobility in women. Int Urogynecol J. 2009;20:177–83.

    Article  Google Scholar 

  61. Van Veggel L, Morrell M, Harris C, Dormans-Linssen M. A new devise for the treatment of female stress urinary incontinence. Proc Inst Mech Eng H. 2003;217(4):317–21.

    Article  PubMed  Google Scholar 

  62. Wu JM, Hundley AF, Fulton RG, Myers ER. Forecasting the prevalence of pelvic floor disorders in U.S. women 2010-2050. Obstet Gynecol. 2009;114:1278–83.

    Article  PubMed  Google Scholar 

  63. Macroplastique® Implants Instructions for Use. http://www.uroplasty.com/files/pdf/4226.pdf, Accessed 10 Oct 2013.

Download references

Author information

Authors and Affiliations

  1. Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, Cleveland Clinic, 9500 Euclid Avenue, A-81, Cleveland, OH, 44195, USA

    Megan E. Tarr M.D., M.S.

Authors
  1. Megan E. Tarr M.D., M.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Megan E. Tarr M.D., M.S. .

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecolog, Cleveland Clinic, Willoughby Hills, Ohio, USA

    Jonathan D. Emery

  2. Department of Obstetrics and Gynecology, Cleveland Clinic, Cleveland, Ohio, USA

    Marie Fidela R. Paraiso

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Tarr, M.E. (2015). Peri-urethral Injections. In: Emery, J., Paraiso, M. (eds) Office-Based Gynecologic Surgical Procedures. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1414-2_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1414-2_13

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1413-5

  • Online ISBN: 978-1-4939-1414-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation